Could a weekly shot help tame type 1 diabetes?
NCT ID NCT06630585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a weekly medicine called tirzepatide to usual insulin therapy helps adults with type 1 diabetes control their blood sugar better. About 42 people aged 18-65 who already use an automated insulin pump will take part. The goal is to see if the combination leads to more time with blood sugar in a healthy range.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DiaCenTRE - Hirslanden Clinique des Grangettes
RECRUITINGChêne-Bougeries, Canton of Geneva, 1224, Switzerland
-
Kantonsspital Olten
RECRUITINGOlten, Canton of Solothurn, 4600, Switzerland
-
Luzerner Kantonspital
RECRUITINGLucerne, 6000, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Open-Source insulin systems match commercial ones without meal announcements?
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Immune cell study may unlock kidney protection in type 1 diabetes
- Could an arthritis drug stop type 1 diabetes before it starts?